Stanley Jacot's most recent trade in Arcadia Biosciences Inc was a trade of 5,000 Common stock done at an average price of $4.3 . Disclosure was reported to the exchange on May 30, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcadia Biosciences Inc | Stanley Jacot | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 30 May 2023 | 5,000 | 5,000 (0%) | 0% | 4.3 | 21,550 | Common stock |
Arcadia Biosciences Inc | Stanley Jacot | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 1,500 | 9,402 | - | - | Stock Option (Right to Buy) | |
Arcadia Biosciences Inc | Stanley Jacot | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 316,108 | 316,108 | - | - | Stock Option (right to buy) |